RE: Under the radar18 May 2026 16:33
For any biotech getting clearance for a phase 3 trial is huge news, never mind a registrational phase 3 !!
Also for those that remember, Richard Goodfellow said scancell were not looking to affect an incremental improvement in cancer treatment .. they are aiming for a step change. Well , looking at the most recent data from iscib1+ phase 2 , he’s not wrong ! (So far) ..
Take care all ..